Evoke Wealth’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,769
Closed -$374K 98
2026
Q1
$374K Buy
1,769
+177
+11% +$38.1K 0.01% 479
2025
Q4
$327K Buy
+1,592
New +$300K 0.01% 499
2022
Q4
Sell
-124
Closed -$8K 483
2022
Q3
$8K Hold
124
﹤0.01% 787
2022
Q2
$7K Sell
124
-11
-8% -$625 ﹤0.01% 824
2022
Q1
$8K Buy
135
+57
+73% +$3.05K ﹤0.01% 799
2021
Q4
$4K Hold
78
﹤0.01% 928
2021
Q3
$3K Sell
78
-2
-3% -$108 ﹤0.01% 932
2021
Q2
$5K Sell
80
-3
-4% -$175 ﹤0.01% 856
2021
Q1
$5K Hold
83
﹤0.01% 830
2020
Q4
$4K Hold
83
﹤0.01% 750
2020
Q3
$4K Sell
83
-22
-21% -$1.13K ﹤0.01% 697
2020
Q2
$6K Buy
105
+26
+33% +$1.34K ﹤0.01% 622
2020
Q1
$3.83K Sell
79
-2,336
-97% -$121K ﹤0.01% 668
2019
Q4
$123K Buy
2,415
+9
+0.4% +$465 0.02% 298
2019
Q3
$115K Buy
+2,406
New +$110K 0.01% 346

Other funds holding CAH

Evoke Wealth's CAH Position: Q2 2026 in Review

Evoke Wealth sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 1,769 shares — an estimated $374K sold.

Evoke Wealth first reported a position in CAH in Q3 2019 and held it in 15 quarters. The position peaked at $374K in Q1 2026. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Evoke Wealth reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
  • Evoke Wealth sold 1,769 Cardinal Health shares in Q2 2026, an estimated $374K.
  • Evoke Wealth first reported a position in Cardinal Health in Q3 2019 and held it in 15 quarters.
  • Evoke Wealth's Cardinal Health position peaked at $374K in Q1 2026.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.